Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
Clinical use of a totally heparin grafted hemodialysis system in uremic patientsG Schmer, L N Teng, J E Vizzo, et al.Artificial Organs|February 1, 1978
Uremic neuropathy: evidence of middle molecule toxicityJ Milutinovic, A L Babb, J W Eschbach, et al.Diabetes, Obesity & Metabolism|January 23, 2016
Safety, pharmacokinetics and pharmacodynamics of BI 135585, a selective 11β-hydroxysteroid dehydrogenase-1 (HSD1) inhibitor in humans: liver and adipose tissue 11β-HSD1 inhibition after acute and multiple administrations over 2 weeksS Freude, T Heise, H-J Woerle, et al.Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2010
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetesT Forst, B Uhlig-Laske, A Ring, et al.Clinical Therapeutics|July 20, 2010
Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjectsAkiko Sarashina, Shogo Sesoko, Mitsuyoshi Nakashima, et al.Clinical Therapeutics|July 5, 2011
Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patientsYoshiharu Horie, Shigeto Kanada, Hirotaka Watada, et al.Journal of Clinical Pharmacology|May 22, 2001
Pharmacokinetics and bioavailability of quercetin glycosides in humansE U Graefe, J Wittig, S Mueller, et al.Clinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulationJ M Leitner, B Jilma, F B Mayr, et al.Pageof 4